Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameHuman Health
Stock Code01419
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities香港私營綜合醫療服務營運商,提供全科醫療、專科醫療及牙科服務,擁有66間醫務中心網絡。
Listing Date2016-04-01
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港九龍九龍灣常悅道3號企業廣場2期12樓
Business Address (Hong Kong)香港九龍尖沙咀柯士甸道45–53號聯業大廈11樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehumanhealth.com.hk
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 1.38 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueRMB 0.01 / shares
Offer Period2016-03-17 to 2016-03-22
Global Offering Shares76,680,000 shares
HK Public Offer Shares (Initial)7,668,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)69,012,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO350,000,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone Share7.0%
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 105,818,400

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 292.9M
Est. Threshold HK$ 9.73B
Analysis Result HK market cap below threshold, need +3221%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利约35.7百万港元
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 HKD
Income Statement
Item 2013-062014-062015-062015-09
Revenue 333,933365,246429,538110,786
Cost of sales -181,740-191,527-230,293-59,415
Gross profit 152,193173,719199,24551,371
Other income and gains, net 2,4755801,815427
Administrative expenses -111,035-124,938-155,879-45,334
Share of associates and JVs 000-37
Profit before tax 43,63349,36145,1816,427
Income tax expense -7,005-8,604-9,463-1,858
Profit for the year 36,62840,75735,7184,569
Profit attributable to owners 34,09338,74833,7274,569
Balance Sheet
Item 2013-062014-062015-062015-09
Cash and cash equivalents 88,32691,416109,24896,578
Trade and bills receivables 21,42424,84131,88830,359
Inventories 3,6674,7977,2956,729
Total current assets 121,146131,862164,311154,951
Total assets 142,267154,130231,920226,823
Total current liabilities 48,36456,003114,138104,458
Total liabilities 48,49656,082116,921107,255
Total equity 93,77198,048114,999119,568
Equity attributable to owners 85,60988,304114,999119,568
Cash Flow Statement
Item 2013-062014-062015-062015-09
Net cash from operating activities 38,97041,34655,235-3,470
Net cash from investing activities -5,798-6,956-31,903-4,205
Net cash from financing activities -18,329-31,300-5,500-4,995
Net increase in cash 14,8433,09017,832-12,670
Depreciation of PP&E 6,1555,9366,0821,645
Amortisation of intangible assets 00722403
Purchase of PP&E -5,586-7,284-5,682-605
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 1.99
First Day OpenHK$ 1.85
First Day Change44.20%
First Day Volume180834000.0
First Day Turnover361008000.0
Use of Proceeds
1、約31.5百萬港元(相當于所得款項凈額的46.0%)將用于為在香港透過設立六間新專科醫務中心以擴充本集團的醫務中心網絡提供部分資金; 2、約4.8百萬港元(相當于所得款項凈額的7.0%)將用于為在香港透過設立六間新全科醫務中心擴充本集團的醫務中心網絡提供部分資金; 3、約10.3百萬港元(相當于所得款項凈額的15.0%)將用于為本集團擴充至中國市場提供部分資金; 4、約6.9百萬港元(相當于所得款項凈額的10.0%)將用于在香港收購已設立的醫務中心; 5、約4.1百萬港元(相當于所得款項凈額的6.0%)將用于在香港透過聘請品牌顧問、進行品牌建設活動及翻新及維護我們現有醫務中心以提升我們的品牌形象; 6、約4.1百萬港元(相當于所得款項凈額的6.0%)將用于提升我們的信息科技基建設施; 7、約6.9百萬港元(相當于所得款項凈額的10.0%)將用于營運資金及其他一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
BOCOM International (Asia) Limited CE API271
Overall Coordinators (1)
交银国际证券有限公司 CE APJ121
Joint Bookrunners (2)
交银国际证券有限公司 CE APJ121 China Sunrise Securities (International) Limited CE AFS030
Joint Lead Managers (4)
交银国际证券有限公司 CE APJ121 China Sunrise Securities (International) Limited CE AFS030 RHB SECURITIES HONG KONG LIMITED CE ADU220 EVERHOT SECURITIES LIMITED CE ABH246

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 首都医疗国际有限公司 34,011,480 HKD — 7.04% — 6 months 2016-10-01

Directors & Management

PositionChinese nameEnglish Name
Chairman陳健平—
Company Secretary薩翠雲—
No director data available.

Major Shareholders

Major Shareholders & HoldingsTreasure Group、陳先生及彭醫生為控股股東,合共持有本公司72.10%權益。
About this page

This page shows Human Health (01419) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect